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Objectives: Vivax malaria has reemerged and become endemic in Korea. Our
study aimed to analyze by both longitudinal and cross-sectional genetic diversity
of this malaria based on the P vivax Merozoite Surface Protein (PvMSP) gene
parasites recently found in the Korean peninsula.
Methods: PvMSP-1 gene sequence analysis from P vivax isolates (nZ 835) during
the 1996-2010 period were longitudinally analyzed and the isolates from the
Korean peninsula through South Korea, the demilitarized zone and North Korea
collected in 2008-2010 were enrolled in an overall analysis of MSP-1 gene
diversity.
Results: New recombinant subtypes and severe multiple-cloneinfection rates
were observed in recent vivax parasites. Regional variation was also observed in
the study sites.
Conclusion: This study revealed the great complexity of genetic variation and
rapid dissemination of genes in P vivax. It also showed interesting patterns of
diversity depending, on the region in the Korean Peninsula. Understanding the
parasiteninsula. Under genetic variation may help to analyze trends and assess
the extent of endemic malaria in Korea.ibuted under the terms of the Creative Commons Attribution Non-Commercial License
y-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in
is properly cited.
ributed equally to this study.
ase Control and Prevention. Published by Elsevier Korea LLC. All rights reserved.
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Plasmodium vivax is the most widespread human
malarial species [1] and has reemerged in many regions
of the world where malaria was eliminated in the 1950
and 1960s [1,2]. Until the late 1970s, P vivax malaria
(vivax malaria) was highly endemic in the Korean
Peninsula [3e5]. Subsequently, malaria was eradicated
in South Korea (SK) [6], but reemerged in 1993 [7].
Vivax malaria outbreaks in SK and have been correlated
to those of North Korea (NK) [3,4]. The fraction of
soldiers with malaria during an outbreak has usually
been >50% in SK in the past. The patient population has
now shifted to include a majority of non-military
personnel. It is obvious that malaria is endemic and is
once again a serious public health threat in SK.
Previously we reported that the recently collected
isolates were completely different from those in the
initial period (1996e2000) and that this diversity
showed rapid insemination in the recent samples [8]. In
the present study, we have further analyzed recent vivax
malaria parasites using both longitudinal (1996-2010)
and cross-sectional genetic analysis. For regional char-
acterization, civilian patients from SK, military patients
from the DMZ (demilitarized zone) and patients from
NK were enrolled. Within SK, the major malaria risk
regionseGangwha and Chelwon counties and Paju and
Gimpo cities adjacent to the southern DMZewere
analyzed. In addition, the multiple-clone infection rates
in Korean vivax malaria patients were investigated. In
this study, theMSP-1 gene polymorphism of recent vivax
isolates in the Korean Peninsula was demonstrated.2. Materials and Methods
2.1. Malaria incidence and burden in Korea
The methods of spot map generation and malaria
incidence rates in SK and NK were described in
supplementary methods online.
2.2. Sample preparation
From 1996e2010 (except for 1997), blood was
collected by venipuncture from 835 patients with
confirmed vivax malaria who had never been abroad.
DNA was extracted from 200 ml of each blood sample
using a QIAamp DNA Mini Kit (Qiagen, Valencia,
CA, USA) following the manufacturer’s instructions.
Eight-hundred-thirty-five patient samples were used for
longitudinal analysis based on the MSP-1 gene. For the
regional analysis based on MSP-1 gene diversity, the
following were included:
 208 civilian samples from endemic areas in SK
collected in 2007e2010;
 111 samples taken from soldiers in the DMZ in
2008; and 28 isolates from NK that were collected between
2007 and 2010.
2.3. PCR amplification and sequencing of
MSP-1 gene
Genomic DNAs obtained from the 835 patients
during 1996e2010 were analyzed and compared to our
previous study [8]. The amplified region of the MSP-1
gene included the sequence between Internal conserved
block (ICB) 5 and 6 [9]. The products from the poly-
merase chain reaction (PCR) were purified and
sequenced using an ABI 3730XL DNA Analyzer auto-
mated sequencer (Applied Biosystems, USA). For the
multiple clone infection analysis, each PCR product was
cloned using a TOPO-TA cloning kit (Invitrogen Corp.,
USA) and 10 colonies of each PCR product were puri-
fied and sequenced. Detailed sequence analysis infor-
mation is described in the supplementary methods
online at doi:10.1016/j.phrp.2011.11.039.3. Results
3.1. Prevalence of the reemerged P vivax
malaria in Korea
A spot map was made of a malaria outbreak
including three patient groups in SK (civilians, soldiers
in the DMZ and discharged soldiers) and the risk areas
in SK (supplementary Figure 1). The prevalence of
malaria in SK and NK during 1999e2009 is presented in
the supplementary Figure 2.
3.2. Longitudinal analysis on MSP-1gene
diversity
The block 5 of PvMSP-1 polymorphism among 835
isolates including the previous data [8] was analyzed.
Three MSP-1 types (Sal-1, Belem and Recombinant)
have been appeared in Korean vivax isolates. Sal-1
showed major frequency (over 50%) since 2003 (see
supplementary Table 2). In the subtype analysis, S-a
and S-b were the major Sal-1 subtypes. Only B1 subtype
has been observed except 2006 since its appearance
(Figure 1). New recombinant subtypes with different
numbers of Q-repeats (10Q, 12Q, 14Q and 27Q)
were found in patients in 2010 and named R1 R2, R3
and R4, respectively (Figure 2).
3.3. Comparison of MSP-1 genotypes in the
Korean peninsula: SK, DMZ and NK
MSP-1 gene diversity of civilians in SK, soldiers in the
DMZ and the NK samples collected over 3 years
(2007e2010) were analyzed. The variation in MSP-1
types in soldiers was similar to that seen in SK. In NK,
however, the recombinant type was predominant
(53.6%), followed by Sal-1 (32.1%) and Belem (14.3%),
see Figure 3A. The frequency of the S-b subtype (28.9%)
was slightly higher than the S-a subtype (23.6%) in SK.
Figure 1. Frequency of PvMSP strains in Korea during the study period. Between 1996 and 2000, the majority of the Korean
isolates have changed from recombinant to Sal-1. Black spots indicate the recombinant subtypes, white spots indicate the Sal-1
subtype and white spots with a smaller spot inside indicate the Belem subtypes. No spot region indicates only one subtype
(S-b, B-1 and R1) without variation;B: S-a subtype, : S-a and S-c subtypes; ◎: B-2 subtype);CCC: R2, R3 and R4 subtypes.
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in the DMZ (27% and 28.8%, respectively). In the North
Korean isolates, a high portion of recombinant type
(53.6%) was observed. The incidence of the S-b subtype
(21.4%) was much higher than S-a (10.7%). In Belem
subtypes, there were similar frequency rates (14.3e
17.3%) in the three regions, see Figure 3B.
3.4. Cross-sectional genotyping in malaria risk
regions in South Korea
The 208 samples collected from Gangwha (NZ 83),
Gimpo (N Z 15), Paju (N Z 27) and CheorwonFigure 2. Comparison of amino acid sequences of the PvMSP-1
positions indicated by the shaded regions depict non-synonymous(N Z 32), and other regions including potential risk
areas (N Z 51) in 2006e2010 were enrolled.
Gangwha, Gimpo and Paju are located in the western
part of SK, while Cheorwon is located in the middle
of the risk areas (see Figures 4 and supplementary
Figure 1). Other regions include the potential risk
regions and scattered samples in SK, as described in
the spot map (supplementary Figure 1). A similar
pattern of subtype variation was observed in Gang-
wha, Paju and other areas with a risk of vivax
malaria. A relatively higher portion (40%) of B-1
type was, however, shown in Gimpo isolates and onlyprotein found in SK with worldwide strains. The amino acid
substitutions and poly-Q residues in the Korean isolates.
Figure 3. (A) The portions of MSP-1 types; and (B) its subtypes in patients from SK, the DMZ and NK.
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(Figure 4).
3.5. Prevalence of mixed-clone infection in
P vivax
We invested the multiple clone infection rates in
vivax patients. Eighty-eight isolates from SK, 22 isolates
from DMZ soldiers and 23 isolates from NK that were
collected during 2007 and 2008 were analyzed. We
observed 56.5% mixed-clone infection rates in SK, 77%
in the DMZ and 32% in NK. In further analysis of the
major risk regions in SK, multiple infection rates varied
from 41.7e73.3% and double, triple or even quadruple
clones were observed, as described in Table 1.Figure 4. The diversity in MSP-1 subtypes depending on the maj
Gimpo, Paju, etc.).4. Discussion
The present longitudinal (1996e2010) and cross-
sectional analysis of three regions in the Korean
Peninsula provided more evidence of the complexity of
genetic variation and supports the previous study [8]. As
described in the supplementary Figures 1 and 2, the
prevalence of vivax malaria NK is slightly different to
that in SK. The border region is the most important
region for malaria control in the Korean Peninsula.
Since 2 years of military duty is mandatory for Korean
men and soldiers make up about half of the long-term
latent patients in Korea [10], patients are usually
grouped into three bands: soldiers, discharged soldiersor malaria risk areas in Korea (Gangwha, Bucheon, Cheolwon,
Table 1. Proportion of mixed-clone infections in P vivax isolates from the risk areas in South Korea
Area Gangwha Cheorwon Gimpo Paju Potential risk area
Multiplicity n (%) n (%) n (%) n (%) n (%)
Single 10 (35.7) 4 (26.7) 7 (58.3) 14 (46.7) 11 (50.0)
Double 10 (35.7) 10 (66.7) 2 (16.7) 13 (43.3) 8 (36.4)
Triple 7 (25.0) 1 (6.7) 2 (16.7) 3 (10.0) 2 (9.1)
Quadruple 1 (3.6) 1 (8.3) 1 (4.5)
Total no (n) 28 15 12 30 22
Mixed infection rate (%) 64.3 73.3 41.7 53.3 50
162 J.-Y. Kim, et al(DS) and civilians, as shown in the spot map
(supplementary Figure 1A).
Park et al [5] showed that the portion of civilians with
vivax malaria has increased. Until recently, the propor-
tion of soldiers including DS has made up almost half of
the total number of vivax malaria cases [6]. In this
regard, this study including three groupseSK, NK
samples and DMZ soldierseprovides valuable data for
genetic research into vivax malaria.
The PvMSP-1 protein expressed on the surface of the
malaria merozoite [11] is organized in several variable
blocks flanked by 10 conserved sections [12]. Block 5
shows a dimorphic pattern of sequences that have little
homology [13]. PvMSP-1 has been used as a poly-
morphic marker to study genetic structure of P vivax
populations and is also a valuable epidemiological
marker in endemic areas [12,14e16]. In this study, we
have reviewed the block 5 PvMSP-1 polymorphism
among isolates collected in SK from 1996e2010. The
result of the variation pattern was not very different to
the previous study [8]. Interestingly, however, we found
new recombinant subtypes with different numbers of Q
residue repeats (12Q, 14Q and 27Q) from indige-
nous Korean patients in 2010 (Figure 2). 12Q, and
27Q subtypes were found in Ganghwa and 14Q
subtype was found in Gimpo. The 12Q subtype has
only ever been found in Azerbaijan [17] but recombi-
nant 14Q and 27Q subtypes have been newly found
in the present study. The origination of these new
recombinant subtypes is unclear, but their appearance
might be further evidence of the rapid dissemination of
newly introduced P vivax, as described in our previous
study [8], and they show the complexity of genotypes in
Korean vivax malaria. Choi et al [18] described an
imported case of vivax case that broke out in an endemic
area in Korea like an indigenous case. They suggested
that imported cases might increase the diversity of vivax
genotypes in Korean peninsula. These results suggest
that there is great need for further surveillance of genetic
diversity in P vivax.
In this study we tried to investigate the three groups
of vivax patients; civilian patients in SK and NK and
soldiers with malaria in the DMZ. Several researchers
have suggested that the P vivax malaria situation in SKhas been directly influenced by infected mosquitoes
originating from NK [19,20]. The relative risk on vivax
prevalence of NK to SK is very high (supplementary
Figure 2). Since the number of NK isolates was rela-
tively small, we were unable to find the direct rela-
tionship of genotypes found in SK and NK. It was, at
least, was very clear that DMZ isolates were closely
related the isolates from SK patients. It seems that SK
has its own malaria transmission cycle. Moreover, it is
meaningful that the present study showed the recent
change in the diversity of isolates from soldiers in
Korea. We also carried out a cross-sectional study in
SK. As described in Figure 4, the diversity of isolates
in Cherwon was unique compared to other areas. The
portion of the S-b subtype was higher than S-a, and
a very high frequency of B-1 was observed. There were
also a relatively lower number of recombinant subtypes
found. Cherwon is located in the middle of the risk areas
(Figure 4) and has different geographical features. Jun
et al [3] suggested that the west part of malaria risk areas
in SK can be influenced by the malaria situation in NK.
It seems that a different transmission cycle correlates
with NK and in Cheorwon area. This study suggests that
there we need to survey the genotypes of NK isolates,
using a large sample size to demonstrate the genotyping
status in the Korean Peninsula.
Finally we investigated the proportion of mixed clone
infection. A high proportion of mixed clone infection
(77%) was observed in DMZ isolates. This might
support the hypothesis that the DMZ is the pathway for
malaria transmission in the Korean Peninsula. Although
NK isolates showed the lowest mixed clone infection
rates (33%), the small numbers of samples might be
used to represent status of vivax malaria NK. In further
analysis among SK isolates, Cheorwon isolates showed
the highest proportion of mixed infection (73.3%), and
was similar to that of DMZ isolates. Ganghwa, the
highest risk area for Korean civilians followed, with
64.3% having mixed infection. Double-, triple- or four-
clone infections were found in the study sites. It has
been reported that 38% of mixed infections were
observed in Papua New Guinea, 33.3% in Thailand,
0.7% in India and 44.8% in Colombia [21]. Korea is
considered a hypoendemic area for malaria. Cui [22]
P vivax genetic diversity in the Korean peninsula 163reported that relatively low genetic diversity has been
detected in the reemerging P vivax malaria in Korea. In
this study, however, Korea showed the extremely high
rates of mixed clone infection. This study contradicts the
previous results [22] and provides evidence of the
complexity of genetic vivax malaria diversity in Korea.
Recently Han et al [23] reported that the allelic diversity
of Pvmsp-1 was increased in Korean isolates.5. Conclusion
Our overall study on vivax malaria in the Korean
Peninsula revealed the high complexity of genetic
variation and rapid dissemination of P vivax genes. It
also showed interesting patterns of diversity, depending
on the regions analyzed in the Korean Peninsula.
Understanding the patterns of P vivax genetic may help
us analyze trends and assess the extent of endemic
malaria in Korea.Acknowledgement
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